UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 154

Sortiert nach

Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots following Directly Observed Therapy

Antimicrobial agents and chemotherapy, 2018-01, Vol.62 (1)

2018

Link zum Volltext

Verfügbarkeit prüfen

Direct-Acting Antiviral Agents for Hepatitis C Virus Infection

Annual review of pharmacology and toxicology, 2013-01, Vol.53 (1), p.427-449

2013

Link zum Volltext

Verfügbarkeit prüfen

Review article: clinical pharmacology of current and investigational hepatitis B virus therapies

Alimentary pharmacology & therapeutics, 2020-01, Vol.51 (2), p.231-243

2020

Link zum Volltext

Verfügbarkeit prüfen

Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure

AIDS research and human retroviruses, 2013-02, Vol.29 (2), p.384

2013

Link zum Volltext

Verfügbarkeit prüfen

Application of an intracellular assay for determination of tenofovir-diphosphate and emtricitabine-triphosphate from erythrocytes using dried blood spots

Journal of pharmaceutical and biomedical analysis, 2016-04, Vol.122, p.16-20

2016

Link zum Volltext

Verfügbarkeit prüfen

Drug-drug interactions during antiviral therapy for chronic hepatitis C

Nature reviews. Gastroenterology & hepatology, 2013-10, Vol.10 (10), p.596

2013

Link zum Volltext

Verfügbarkeit prüfen

Optimizing hepatitis C virus treatment through pharmacist interventions: Identification and management of drug-drug interactions

World journal of gastroenterology : WJG, 2017-03, Vol.23 (9), p.1618-1626

2017

Link zum Volltext

Verfügbarkeit prüfen

Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots Following Tenofovir Alafenamide: The TAF-DBS Study

Journal of acquired immune deficiency syndromes (1999), 2020-07, Vol.84 (3), p.323

2020

Link zum Volltext

Verfügbarkeit prüfen

Effect of Disease Pathologies on Transporter Expression and Function

Journal of clinical pharmacology, 2016-07, Vol.56 (S7), p.S205-S221

2016

Link zum Volltext

Verfügbarkeit prüfen

Plasma and Intracellular Population Pharmacokinetic Analysis of Tenofovir in HIV-1-Infected Patients

Antimicrobial Agents and Chemotherapy, 2011-11, Vol.55 (11), p.5294-5299

2011

Link zum Volltext

Verfügbarkeit prüfen

Intracellular Tenofovir and Emtricitabine Anabolites in Genital, Rectal, and Blood Compartments from First Dose to Steady State

AIDS research and human retroviruses, 2016-11, Vol.32 (10-11), p.981

2016

Link zum Volltext

Verfügbarkeit prüfen

Drug/Drug interaction between lopinavir/ritonavir and rosuvastatin in healthy volunteers

Journal of acquired immune deficiency syndromes (1999), 2008-04, Vol.47 (5), p.570

2008

Link zum Volltext

Verfügbarkeit prüfen

Safety of Hepatitis C Viral Protease Inhibitors in Compensated Cirrhotics: Lingering Concerns Put to Rest?

Clinical infectious diseases, 2019-10, Vol.69 (10), p.1665-1666

Kiser, Jennifer J

2019

Link zum Volltext

Verfügbarkeit prüfen

Model Linking Plasma and Intracellular Tenofovir/Emtricitabine with Deoxynucleoside Triphosphates

PloS one, 2016-11, Vol.11 (11), p.e0165505

2016

Link zum Volltext

Verfügbarkeit prüfen

Association of Higher Plasma Vitamin D Binding Protein and Lower Free Calcitriol Levels with Tenofovir Disoproxil Fumarate Use and Plasma and Intracellular Tenofovir Pharmacokinetics: Cause of a Functional Vitamin D Deficiency?

Antimicrobial Agents and Chemotherapy, 2013-11, Vol.57 (11), p.5619-5628

2013

Link zum Volltext

Verfügbarkeit prüfen

Serum and cellular ribavirin pharmacokinetic and concentration-effect analysis in HCV patients receiving sofosbuvir plus ribavirin

Journal of antimicrobial chemotherapy, 2015-08, Vol.70 (8), p.2322-2329

2015

Link zum Volltext

Verfügbarkeit prüfen

Prospects for Long-Acting Treatments for Hepatitis C

Clinical infectious diseases, 2022-11, Vol.75 (Suppl 4), p.S525-S529

2022

Link zum Volltext

Verfügbarkeit prüfen

Effect of Antacids on the Pharmacokinetics of Raltegravir in Human Immunodeficiency Virus-Seronegative Volunteers

Antimicrobial Agents and Chemotherapy, 2010-12, Vol.54 (12), p.4999-5003

2010

Link zum Volltext

Verfügbarkeit prüfen

Safety and Feasibility of Antiretroviral Preexposure Prophylaxis for Adolescent Men Who Have Sex With Men Aged 15 to 17 Years in the United States

JAMA pediatrics, 2017-11, Vol.171 (11), p.1063

2017

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic Interactions between the Hormonal Emergency Contraception, Levonorgestrel (Plan B), and Efavirenz

Infectious Diseases in Obstetrics and Gynecology, 2012, Vol.2012, p.137192-4

2012

Link zum Volltext

Verfügbarkeit prüfen

The use of technology-based adherence monitoring in the treatment of hepatitis C virus

Therapeutic Advances in Infectious Disease, 2022, Vol.9, p.204993612210956

2022

Link zum Volltext

Verfügbarkeit prüfen

Long-Acting Treatments for Hepatitis B

Clinical infectious diseases, 2022-11, Vol.75 (Suppl 4), p.S517-S524

2022

Link zum Volltext

Verfügbarkeit prüfen

Cumulative Tenofovir Exposure Among Patients With Human Immunodeficiency Virus/Hepatitis B Coinfection With Differential Viral Suppression

Clinical infectious diseases, 2024-05

2024

Link zum Volltext

Verfügbarkeit prüfen

Antiviral Treatment Failures After Transplantation of Organs From Donors With Hepatitis C Infection: A Report of 4 Cases

American journal of kidney diseases, 2023-09, Vol.82 (3), p.368-372

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 154

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(122)
Mit Volltextzugriff
(129)

Publikationsform

Artikel
(125)
Buchkapitel
(22)
Bücher
(4)
Berichte
(3)

Sprache

Englisch
(154)
Japanisch
(15)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots following Directly Observed Therapy

Direct-Acting Antiviral Agents for Hepatitis C Virus Infection

Review article: clinical pharmacology of current and investigational hepatitis B virus therapies

Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure

Application of an intracellular assay for determination of tenofovir-diphosphate and emtricitabine-triphosphate from erythrocytes using dried blood spots

Drug-drug interactions during antiviral therapy for chronic hepatitis C

Optimizing hepatitis C virus treatment through pharmacist interventions: Identification and management of drug-drug interactions

Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots Following Tenofovir Alafenamide: The TAF-DBS Study

Effect of Disease Pathologies on Transporter Expression and Function

Plasma and Intracellular Population Pharmacokinetic Analysis of Tenofovir in HIV-1-Infected Patients

Intracellular Tenofovir and Emtricitabine Anabolites in Genital, Rectal, and Blood Compartments from First Dose to Steady State

Drug/Drug interaction between lopinavir/ritonavir and rosuvastatin in healthy volunteers

Safety of Hepatitis C Viral Protease Inhibitors in Compensated Cirrhotics: Lingering Concerns Put to Rest?

Model Linking Plasma and Intracellular Tenofovir/Emtricitabine with Deoxynucleoside Triphosphates

Association of Higher Plasma Vitamin D Binding Protein and Lower Free Calcitriol Levels with Tenofovir Disoproxil Fumarate Use and Plasma and Intracellular Tenofovir Pharmacokinetics: Cause of a Functional Vitamin D Deficiency?

Serum and cellular ribavirin pharmacokinetic and concentration-effect analysis in HCV patients receiving sofosbuvir plus ribavirin

Prospects for Long-Acting Treatments for Hepatitis C

Effect of Antacids on the Pharmacokinetics of Raltegravir in Human Immunodeficiency Virus-Seronegative Volunteers

Safety and Feasibility of Antiretroviral Preexposure Prophylaxis for Adolescent Men Who Have Sex With Men Aged 15 to 17 Years in the United States

Pharmacokinetic Interactions between the Hormonal Emergency Contraception, Levonorgestrel (Plan B), and Efavirenz

The use of technology-based adherence monitoring in the treatment of hepatitis C virus

Long-Acting Treatments for Hepatitis B

Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection

Cumulative Tenofovir Exposure Among Patients With Human Immunodeficiency Virus/Hepatitis B Coinfection With Differential Viral Suppression

Antiviral Treatment Failures After Transplantation of Organs From Donors With Hepatitis C Infection: A Report of 4 Cases

Suchergebnisse filtern